Start Over

Medicine price awareness in chronic patients in Belgium.

Authors :: Fraeyman J
Symons L
De Loof H
De Meyer GR
Remmen R
Beutels P
Van Hal G
Source :: Health policy (Amsterdam, Netherlands) [Health Policy] 2015 Feb; Vol. 119 (2), pp. 217-23. Date of Electronic Publication: 2014 Dec 08.
Publication Year :: 2015
Abstract: Introduction: Under increasing pressure to contain health expenditures governments across Europe have implemented policies to increase responsible medicine use, e.g. by increasing co-insurance paid for by patients. In times of austerity, how do chronic disease patients perceive the medicine price they have to pay?<br />Method: We used a mixed methods research design. First, we distributed a close-ended questionnaire among 983 chronic disease patients in 30 Flemish pharmacies. Second, we performed semi-structured interviews with 15 of these patients. We surveyed for knowledge on the prescription medicine they bought, as well as for their needs for information and their therapeutic compliance.<br />Results: Although patients express a lack (and a need) of information on prices during the consultation with the general practitioner (GP), (s)he hardly addresses medicine prices. Patients often only know the medicine price when they are at the pharmacy and patients need to decide to buy the medicine or not. This often results in patients taking the medicine when considered affordable within their social and financial context.<br />Conclusion: It seems essential that patients are better informed about medicine prices as well as the constraints on physicians to prescribe cost-effectively. Therefore, medicine prices should be discussed more often during physician consults.<br /> (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)